Quadruple combination antidiabetic drugs
Showing 1 - 25 of >10,000
Diabetes, Type 2 Trial (Empagliflozin 25 MG, INS)
Active, not recruiting
- Diabetes Mellitus, Type 2
- Empagliflozin 25 MG
- INS
- (no location specified)
Jul 19, 2022
Type 2 Diabetes Trial in Seoul (TZD group, SGLT-2 group)
Completed
- Type 2 Diabetes Mellitus
- TZD group
- SGLT-2 group
-
Seoul, Korea, Republic ofDivision of Endocrinology and Metabolism, Department of Internal
May 3, 2021
Novel Antidiabetic Drug Combined With Angiotensin
Recruiting
- Type 2 Diabetes
- Antidiabetic Drugs
-
Beijing, Beijing, China
- +1 more
Jun 20, 2023
Dipeptidyl-4 Inhibitors in Reducing Stroke Severity, From HIRA
Not yet recruiting
- Cerebral Infarction
- +2 more
- Dipeptidyl peptidase-4 inhibitor
- (no location specified)
Apr 5, 2023
Type 2 Diabetes Trial in China, Korea, Republic of, United States (Efpeglenatide SAR439977, Placebo, Background therapy)
Terminated
- Type 2 Diabetes Mellitus
- Efpeglenatide SAR439977
- +2 more
-
Birmingham, Alabama
- +46 more
Nov 4, 2021
Diabetic Patients, Type II Diabetes Trial in Sevilla (OA-enriched functional olive oil, commercial olive oil)
Recruiting
- Diabetic Patients
- Type II Diabetes Mellitus
- OA-enriched functional olive oil
- commercial olive oil
-
Sevilla, Andalicía, SpainVirgen del Rocío University Hospital
Sep 1, 2023
H.Pylori Infection Trial in Beijing (Rifasutenizol capsules, Rabeprazole sodium enteric-coated tablets, Amoxicillin Capsules)
Not yet recruiting
- H.Pylori Infection
- Rifasutenizol capsules
- +7 more
-
Beijing, ChinaPeking University Third Hospital
May 3, 2023
Hypertension Trial in Bloomingdale, Chicago (QUARTET LDQT, Candesartan)
Active, not recruiting
- Hypertension
- QUARTET LDQT
- Candesartan
-
Bloomingdale, Illinois
- +1 more
Aug 31, 2022
Efficacy and Safety of Chiglitazar Sodium in the Treatment of T2DM Patients, Metformin Combined With Insulin Glargine in the
Not yet recruiting
- Efficacy and Safety of Chiglitazar Sodium in the Treatment of T2DM Patients
- +6 more
- Chiglitazar sodium
- Chiglitazar placebo
-
Guangzhou, Guangdong, Chinathe First Affiliated Hospital of Sun Yat-sen University
Aug 17, 2023
s and Activity Data in Type 2 Diabetes on Different Treatments
Not yet recruiting
- Diabetes Mellitus, Type 2
- Lifestyle
- +4 more
- (no location specified)
Sep 16, 2022
Hypertension Trial in Brazil (candesartan cilexetil + chlorthalidone + amlodipine, Exforge HCT® (valsartan 160mg +
Not yet recruiting
- Hypertension
- candesartan cilexetil + chlorthalidone + amlodipine
- Exforge HCT® (valsartan 160mg + hydrochlorothiazide 12.5mg + amlodipine 5mg)
-
Rio Branco, AC, Brazil
- +21 more
Jun 26, 2023
Type 2 Diabetes Trial (INS068 injection, Insulin Glargine)
Not yet recruiting
- Type 2 Diabetes
- INS068 injection
- Insulin Glargine
- (no location specified)
Jan 17, 2023
Helicobacter Pylori Eradication Trial in Kaohsiung (esomeprazole, tripotassium dicitrate bismuthate, tetracycline and
Recruiting
- Helicobacter Pylori Eradication
- esomeprazole, tripotassium dicitrate bismuthate, tetracycline and levofloxacin
- +2 more
-
Kaohsiung, TaiwanKaohsiung Medical University Hospital
Apr 28, 2023
Diabetes, Stroke Trial in Chiayi City (Metformin plus Pioglitazone plus an SGLT2 inhibitor)
Recruiting
- Diabetes Mellitus
- Stroke
- Metformin plus Pioglitazone plus an SGLT2 inhibitor
-
Chiayi City, TaiwanChang Gung Memorial Hospital, Chiayi Branch
Jan 11, 2022
Semaglutide in Type 2 Diabetes - A Cohort Study Based on Nordic
Enrolling by invitation
- Diabetes Mellitus, Type 2
- Ozempic®
- +2 more
-
Odense, DenmarkNovo Nordisk Investigational Site
Nov 30, 2022
Optimized Diagnosis and Precision Medicine of MODY
Recruiting
- Maturity-Onset Diabetes of the Young (MODY)
- +2 more
-
Taichung, TaiwanTaichung veterans general hospital
Oct 26, 2023
Diabetes Trial in Minya (MorDom)
Recruiting
- Diabetes
- MorDom
-
Minya, EgyptSoad A. Mohamad
Jun 1, 2023
Hypertension, Arterial Hypertension Trial in Changsha (Quadruple combination of half doses therapy?Dual combination of standard
Recruiting
- Hypertension
- Arterial Hypertension
- Quadruple combination of half doses therapy→Dual combination of standard dose therapy
- Dual combination of standard dose therapy→ Quadruple combination of half doses therapy
-
Changsha, Hunan, ChinaThe Third Xiangya Hospital of Central South University
Jul 13, 2022
Helicobacter Pylori Infection Trial in Shanghai (Esomeprazole, Bismuth Potassium Citrate, Tetracycline)
Recruiting
- Helicobacter Pylori Infection
- Esomeprazole
- +4 more
-
Shanghai, Shanghai, ChinaRenji Hospital, School of Medicine, Shanghai Jiao Tong Universit
May 16, 2023
Helicobacter Pylori Infection Trial in Ljubljana (Bismuth Subcitrate)
Recruiting
- Helicobacter Pylori Infection
- Bismuth Subcitrate
-
Ljubljana, SloveniaMatjaž Homan
Nov 19, 2023
Endothelial Dysfunction, Diabetes, Type 1, Biomarkers Trial in Celje (Semaglutide Pen Injector [Ozempic], Empagliflozin 10 MG)
Completed
- Endothelial Dysfunction
- +9 more
- Semaglutide Pen Injector [Ozempic]
- Empagliflozin 10 MG
-
Celje, SloveniaGeneral Hospital Celje
May 10, 2023
Parkinson Disease, Neurodegenerative Diseases Trial in Karachi (conventional therapy, Saffron and Chamomile, Crocin and
Recruiting
- Parkinson Disease
- Neurodegenerative Diseases
- conventional therapy
- +2 more
-
Karachi, Sindh, PakistanJinnah Postgraduate Medical Centre (JPMC),
Jan 23, 2023
Perioperative Pain Trial in Hackensack (Ibuprofen 600 mg, OxyCODONE 5 Mg Oral Capsule)
Withdrawn
- Perioperative Pain
- Ibuprofen 600 mg
- OxyCODONE 5 Mg Oral Capsule
-
Hackensack, New JerseyHackensack University Medical Center
Sep 7, 2022
Helicobacter Pylori Infection Trial in Shanghai (Esomeprazole, Bismuth Potassium Citrate, Tetracycline,Metronidazole)
Completed
- Helicobacter Pylori Infection
- Esomeprazole
- +3 more
-
Shanghai, Shanghai, ChinaRenji Hospital, School of Medicine, Shanghai Jiao Tong Universit
Nov 10, 2022
Cognitive Protective Effect of Newer Antidiabetic Drugs
Recruiting
- Type 2 Diabetes
- Dapagliflozin
- +6 more
-
Alexandria, EgyptAlexandria University
Jul 24, 2022